Real-world disability improvement in patients with relapsing–remitting multiple sclerosis treated with natalizumab in the Tysabri Observational Program:
2020
Background:Natalizumab has been associated with disability improvement as indicated by a confirmed Expanded Disability Status Scale (EDSS) score decrease.Objective:The aim of this study was to char...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
20
References
2
Citations
NaN
KQI